Christopher E Rudd

11PUBLICATIONS
7CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Reaction engineering (excl. nuclear reactions)Colloid and surface chemistryPredictive and prognostic markersSocial program evaluation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 19, 2026
GSK-3 regulates CD4-CD8 cooperation for super-armed CD8+ cytolytic T cells in immunotherapy against tumors.

|Apr 02, 2025
Comment on: Glycogen synthase kinase 3 controls T-cell exhaustion by regulating NFAT activation.

Bastien Moës, Christopher E Rudd

|Jan 06, 2025
The identification of a SARs-CoV2 S2 protein derived peptide with super-antigen-like stimulatory properties on T-cells.

Thai Hien Tu, Fatima Ezzahra Bennani, Nasser Masroori

|May 03, 2024
Decreased progenitor TCF1 + T-cells correlate with COVID-19 disease severity.

Thai Hien Tu, Ami Grunbaum, François Santinon

|Jan 03, 2024
Stuart Schlossman (1935-2023).

Christopher E Rudd

|Aug 03, 2023
CD8+ T cell killing of MHC class I-deficient tumors.

Christopher E Rudd

Pageof 2

Frequent Collaborators

2 joint publications

Nicholas Rozza

2 joint publications

Chen Liu

1 joint publications

Yiwei Xiong

1 joint publications

Yulan Yi